United States Haemostat Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Haemostat Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Haemostat Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Haemostat Overall Market Size
2.1 United States Haemostat Market Size: 2021 VS 2027
2.2 United States Haemostat Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Haemostat Sales: 2016-2027
3 Company Landscape
3.1 Top Haemostat Players in United States Market
3.2 Top United States Haemostat Companies Ranked by Revenue
3.3 United States Haemostat Revenue by Companies
3.4 United States Haemostat Sales by Companies
3.5 United States Haemostat Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Haemostat Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Haemostat Product Type
3.8 Tier 1, Tier 2 and Tier 3 Haemostat Players in United States Market
3.8.1 List of Tier 1 Haemostat Companies in United States
3.8.2 List of Tier 2 and Tier 3 Haemostat Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Haemostat Market Size Markets, 2021 & 2027
4.1.2 Pituitrin
4.1.3 Hemostatic Sensitivity
4.1.4 Others
4.2 By Type - United States Haemostat Revenue & Forecasts
4.2.1 By Type - United States Haemostat Revenue, 2016-2021
4.2.2 By Type - United States Haemostat Revenue, 2022-2027
4.2.3 By Type - United States Haemostat Revenue Market Share, 2016-2027
4.3 By Type - United States Haemostat Sales & Forecasts
4.3.1 By Type - United States Haemostat Sales, 2016-2021
4.3.2 By Type - United States Haemostat Sales, 2022-2027
4.3.3 By Type - United States Haemostat Sales Market Share, 2016-2027
4.4 By Type - United States Haemostat Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Haemostat Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 ASCs
5.1.5 Others
5.2 By Application - United States Haemostat Revenue & Forecasts
5.2.1 By Application - United States Haemostat Revenue, 2016-2021
5.2.2 By Application - United States Haemostat Revenue, 2022-2027
5.2.3 By Application - United States Haemostat Revenue Market Share, 2016-2027
5.3 By Application - United States Haemostat Sales & Forecasts
5.3.1 By Application - United States Haemostat Sales, 2016-2021
5.3.2 By Application - United States Haemostat Sales, 2022-2027
5.3.3 By Application - United States Haemostat Sales Market Share, 2016-2027
5.4 By Application - United States Haemostat Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Ethicon
6.1.1 Ethicon Corporation Information
6.1.2 Ethicon Overview
6.1.3 Ethicon Haemostat Sales and Revenue in United States Market (2016-2021)
6.1.4 Ethicon Haemostat Product Description
6.1.5 Ethicon Recent Developments
6.2 CSL Behring
6.2.1 CSL Behring Corporation Information
6.2.2 CSL Behring Overview
6.2.3 CSL Behring Haemostat Sales and Revenue in United States Market (2016-2021)
6.2.4 CSL Behring Haemostat Product Description
6.2.5 CSL Behring Recent Developments
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Overview
6.3.3 Pfizer Haemostat Sales and Revenue in United States Market (2016-2021)
6.3.4 Pfizer Haemostat Product Description
6.3.5 Pfizer Recent Developments
6.4 Equimedical BV
6.4.1 Equimedical BV Corporation Information
6.4.2 Equimedical BV Overview
6.4.3 Equimedical BV Haemostat Sales and Revenue in United States Market (2016-2021)
6.4.4 Equimedical BV Haemostat Product Description
6.4.5 Equimedical BV Recent Developments
6.5 Davol
6.5.1 Davol Corporation Information
6.5.2 Davol Overview
6.5.3 Davol Haemostat Sales and Revenue in United States Market (2016-2021)
6.5.4 Davol Haemostat Product Description
6.5.5 Davol Recent Developments
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Overview
6.6.3 Baxter Haemostat Sales and Revenue in United States Market (2016-2021)
6.6.4 Baxter Haemostat Product Description
6.6.5 Baxter Recent Developments
6.7 Hemcon Medical Technologies
6.7.1 Hemcon Medical Technologies Corporation Information
6.7.2 Hemcon Medical Technologies Overview
6.7.3 Hemcon Medical Technologies Haemostat Sales and Revenue in United States Market (2016-2021)
6.7.4 Hemcon Medical Technologies Haemostat Product Description
6.7.5 Hemcon Medical Technologies Recent Developments
6.8 Ceremed
6.8.1 Ceremed Corporation Information
6.8.2 Ceremed Overview
6.8.3 Ceremed Haemostat Sales and Revenue in United States Market (2016-2021)
6.8.4 Ceremed Haemostat Product Description
6.8.5 Ceremed Recent Developments
7 United States Haemostat Production Capacity, Analysis
7.1 United States Haemostat Production Capacity, 2016-2027
7.2 Haemostat Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Haemostat Supply Chain Analysis
9.1 Haemostat Industry Value Chain
9.2 Haemostat Upstream Market
9.3 Haemostat Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Haemostat Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Haemostat in United States Market
Table 2. Top Haemostat Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Haemostat Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Haemostat Revenue Share by Companies, 2016-2021
Table 5. United States Haemostat Sales by Companies, (K Units), 2016-2021
Table 6. United States Haemostat Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Haemostat Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Haemostat Product Type
Table 9. List of Tier 1 Haemostat Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Haemostat Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Pituitrin
Table 12. Major Manufacturers of Hemostatic Sensitivity
Table 13. By Type - United States Haemostat Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Haemostat Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Haemostat Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Haemostat Sales (K Units), 2016-2021
Table 17. By Type - United States Haemostat Sales (K Units), 2022-2027
Table 18. By Application - United States Haemostat Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Haemostat Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Haemostat Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Haemostat Sales (K Units), 2016-2021
Table 22. By Application - United States Haemostat Sales (K Units), 2022-2027
Table 23. Ethicon Corporation Information
Table 24. Ethicon Description and Major Businesses
Table 25. Ethicon Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Ethicon Haemostat Product
Table 27. Ethicon Recent Developments
Table 28. CSL Behring Corporation Information
Table 29. CSL Behring Description and Major Businesses
Table 30. CSL Behring Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. CSL Behring Haemostat Product
Table 32. CSL Behring Recent Developments
Table 33. Pfizer Corporation Information
Table 34. Pfizer Description and Major Businesses
Table 35. Pfizer Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Pfizer Haemostat Product
Table 37. Pfizer Recent Developments
Table 38. Equimedical BV Corporation Information
Table 39. Equimedical BV Description and Major Businesses
Table 40. Equimedical BV Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Equimedical BV Haemostat Product
Table 42. Equimedical BV Recent Developments
Table 43. Davol Corporation Information
Table 44. Davol Description and Major Businesses
Table 45. Davol Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Davol Haemostat Product
Table 47. Davol Recent Developments
Table 48. Baxter Corporation Information
Table 49. Baxter Description and Major Businesses
Table 50. Baxter Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Baxter Haemostat Product
Table 52. Baxter Recent Developments
Table 53. Hemcon Medical Technologies Corporation Information
Table 54. Hemcon Medical Technologies Description and Major Businesses
Table 55. Hemcon Medical Technologies Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Hemcon Medical Technologies Haemostat Product
Table 57. Hemcon Medical Technologies Recent Developments
Table 58. Ceremed Corporation Information
Table 59. Ceremed Description and Major Businesses
Table 60. Ceremed Haemostat Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Ceremed Haemostat Product
Table 62. Ceremed Recent Developments
Table 63. Haemostat Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 64. United States Haemostat Capacity Market Share of Key Manufacturers, 2019-2021
Table 65. Haemostat Market Opportunities & Trends in United States Market
Table 66. Haemostat Market Drivers in United States Market
Table 67. Haemostat Market Restraints in United States Market
Table 68. Haemostat Raw Materials
Table 69. Haemostat Raw Materials Suppliers in United States Market
Table 70. Typical Haemostat Downstream
Table 71. Haemostat Downstream Clients in United States Market
Table 72. Haemostat Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Haemostat Product Picture
Figure 2. Haemostat Segment by Type
Figure 3. Haemostat Segment by Application
Figure 4. United States Haemostat Market Overview: 2020
Figure 5. United States Haemostat Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Haemostat Revenue, 2016-2027 (US$, Mn)
Figure 7. Haemostat Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Haemostat Revenue in 2020
Figure 9. Pituitrin Product Picture
Figure 10. Hemostatic Sensitivity Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - United States Haemostat Sales Market Share, 2016-2027
Figure 13. By Type - United States Haemostat Revenue Market Share, 2016-2027
Figure 14. By Type - United States Haemostat Price (USD/Unit), 2016-2027
Figure 15. Hospital
Figure 16. Clinic
Figure 17. ASCs
Figure 18. Others
Figure 19. By Application - United States Haemostat Sales Market Share, 2016-2027
Figure 20. By Application - United States Haemostat Revenue Market Share, 2016-2027
Figure 21. By Application - United States Haemostat Price (USD/Unit), 2016-2027
Figure 22. Ethicon Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. CSL Behring Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Pfizer Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Equimedical BV Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Davol Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Baxter Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Hemcon Medical Technologies Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Ceremed Haemostat Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. United States Haemostat Production Capacity (K Units), 2016-2027
Figure 31. Haemostat Industry Value Chain
Figure 32. Marketing Channels